Previous Close | 53.9 |
1-Year Change | 9.02% |
6-Months Change | 9.2% |
3-Months Change | -5.11% |
Moving Avg (50d) | 57.359 |
Moving Avg (200d) | 50.413 |
ESG Rating | - |
Exchange | NYSE |
Market Cap. | 109.3B |
Beta (3-Years) | 0.27 |
Revenue Growth (ttm) | 7.32% |
Net Profit Margin (ttm) | -18.53% |
Return On Assets (ttm) | -9.66% |
EPS (ttm) | -4.42 |
PE Ratio (ttm) | -12.19 |
Dividend Yield | 4.49% |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.
Sector: | Health Care |
Industry: | Pharmaceuticals |
Country: | United States |
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion. Bristol Myers Squibb manufactures prescription... Wikipedia